Balabad, Juvelyn .
HRN: 22-38-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/30/2023
CEFAZOLIN 1GM (VIAL)
03/30/2023
04/06/2023
IV
2g
OD X 7 Days
S/P Primary LSTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes